Evidence map›Paper›PMID 24454952›Full record

ArticlePloS one2014

A two-stage association study suggests BRAP as a susceptibility gene for schizophrenia.

Fuquan Zhang, Chenxing Liu, Yong Xu, Guoyang Qi, Guozhen Yuan, Zaohuo Cheng, Jidong Wang, Guoqiang Wang, Zhiqiang Wang, Wei Zhu and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. E3 Ubiquitin LigaseInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Associations ofNeuropsychiatric disease and treatment · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Fuquan ZhangWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China ; Key Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Chenxing LiuKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Yong XuDepartment of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, China.
Guoyang QiWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Guozhen YuanWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Zaohuo ChengWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Jidong WangWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Guoqiang WangWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Zhiqiang WangWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Wei ZhuWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Zhenhe ZhouWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Xingfu ZhaoWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Lin TianWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Chunhui JinWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Janmin YuanWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Guofu ZhangWuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Yaguang ChenKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Lifang WangKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Tianlan LuKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Hao YanKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Yanyan RuanKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Weihua YueKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Dai ZhangKey Laboratory of Mental Health, Ministry of Health, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China ; Peking-Tsinghua Center for Life Sciences, Beijing, China ; PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Nanjing Medical University · CNPeking University Sixth Hospital · CNPeking University · CNShanxi Medical University · CN

Funding

Role of microRNAs in HSC-mediated fibrogenesisR21AA022702 · NIAAA · CAROLINAS MEDICAL CENTER · PI SCHRUM, LAURA W · 2015 to 2016
$378k
NIAAA NIH HHS R21 AA022702
6 · The paper itself

Abstract

Schizophrenia (SZ) is a neurodevelopmental disorder in which altered immune function typically plays an important role in mediating the effect of environmental insults and regulation of inflammation. The breast cancer suppressor protein associated protein (BRAP) is suggested to exert vital effects in neurodevelopment by modulating the mitogen-activated protein kinase cascade and inflammation signaling. To explore the possible role of BRAP in SZ, we conducted a two-stage study to examine the association of BRAP polymorphisms with SZ in the Han Chinese population. In stage one, we screened SNPs in BRAP from our GWAS data, which detected three associated SNPs, with rs3782886 being the most significant one (P  =  2.31E-6, OR  =  0.67). In stage two, we validated these three SNPs in an independently collected population including 1957 patients and 1509 controls, supporting the association of rs3782886 with SZ (P  =  1.43E-6, OR  =  0.73). Furthermore, cis-eQTL analysis indicates that rs3782886 genotypes are associated with mRNA levels of aldehyde dehydrogenase 2 family (ALDH2) (P  =  0.0039) and myosin regulatory light chain 2 (MYL2) (P < 1.0E-4). Our data suggest that the BRAP gene may confer vulnerability for SZ in Han Chinese population, adding further evidence for the involvement of developmental and/or neuroinflammatory cascades in the illness.

Indexed as

Aldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialCase-Control StudiesFemaleGene ExpressionGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansLinkage DisequilibriumMaleMyosin Light ChainsPolymorphism, Single NucleotideQuantitative Trait LociSchizophreniaUbiquitin-Protein LigasesAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanBRAP protein, humanMRLC2 protein, humanMyosin Light ChainsUbiquitin-Protein Ligases

Identifiers

PMID24454952
PMCPMC3893271
OpenAlexW1980985411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.